Old Web
English
Sign In
Acemap
>
Paper
>
462 Clinical Utility of a Highly Sensitive Blood BRAF Assay in Patients with Stage II and III Malignant Melanoma
462 Clinical Utility of a Highly Sensitive Blood BRAF Assay in Patients with Stage II and III Malignant Melanoma
2012
Ryan J. Sullivan
L. Montaser
Alireza Sepehr
Elizabeth I. Buchbinder
Anasuya Gunturi
R. Simonson
James W. Mier
Keith T. Flaherty
Anthony John Iafrate
David J. Panka
Keywords:
Melanoma
Pathology
Medicine
stage ii
highly sensitive
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]